Future Virology · 2020 · 129 citations · 20 references
Veterinary MedicineInfectious DiseasesPharmacotherapyMolecular VirologyVirologyZoonotic DiseasesRespiratory DiseaseRespiratory InfectionsRespiratory Infectious DiseasesViral InfectionsViral PathologyZoonotic VirusesCoronavirus VaccinesMiddle East Respiratory Syndrome CoronavirusPhylogenetic Tree InferenceSars-cov-2 Antiviral TherapySars-cov-2 InfectionSevere Acute Respiratory SyndromeTreatment Of Coronavirus Infections
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first identified in several patients who traveled to Wuhan or went to a seafood wholesale market in Wuhan. The phylogenetic tree showed that SARS-CoV-2 was 96.2% identical to bat β-coronaviruses from lineage B. Also, several studies reported that SARS-CoV-2 uses the SARS-CoV receptor, angiotensin-converting enzyme 2, for entry to target cells. Lung alveolar and small intestine are potential targets for SARS-CoV-2 due to the high expression of the angiotensin-converting enzyme 2 receptor. In this review, we focused on the zoonotic β-coronaviruses and given there is no specific drug or vaccine for coronavirus disease 2019, we reviewed the literature on the therapy options for SARS and Middle East respiratory syndrome coronavirus infection, in order to discover their possible use in the treatment of SARS-CoV-2 infections.
20
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang, Yeming Wang, Xingwang Li et al. · The Lancet · 2020 · 51.8K citations · Full text
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp, Nianshuang Wang, Kizzmekia S. Corbett et al. · Science · 2020 · 9.8K citations · Full text
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Kin‐Hang Kok et al. · The Lancet · 2020 · 9.6K citations · Full text
Veterinary Medicine, Infectious Disease Control, Infectious Diseases +13